JP2015519403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519403A5
JP2015519403A5 JP2015517461A JP2015517461A JP2015519403A5 JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5 JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5
Authority
JP
Japan
Prior art keywords
region
controlled release
mucosa
release polymer
mucoadhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045976 external-priority patent/WO2013188819A2/en
Publication of JP2015519403A publication Critical patent/JP2015519403A/ja
Publication of JP2015519403A5 publication Critical patent/JP2015519403A5/ja
Pending legal-status Critical Current

Links

JP2015517461A 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス Pending JP2015519403A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261659781P 2012-06-14 2012-06-14
US201261659784P 2012-06-14 2012-06-14
US61/659,784 2012-06-14
US61/659,781 2012-06-14
US201261671287P 2012-07-13 2012-07-13
US61/671,287 2012-07-13
PCT/US2013/045976 WO2013188819A2 (en) 2012-06-14 2013-06-14 Mucoadhesive devices for delivery of active agents

Publications (2)

Publication Number Publication Date
JP2015519403A JP2015519403A (ja) 2015-07-09
JP2015519403A5 true JP2015519403A5 (enExample) 2016-07-14

Family

ID=48748504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517461A Pending JP2015519403A (ja) 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス

Country Status (5)

Country Link
US (4) US20150174076A1 (enExample)
EP (1) EP2861220A2 (enExample)
JP (1) JP2015519403A (enExample)
CA (1) CA2915358A1 (enExample)
WO (1) WO2013188819A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102305346B1 (ko) * 2014-09-11 2021-09-28 겔리타 아게 젤라틴/펙틴 입자
DK3006045T3 (en) 2014-10-07 2017-07-17 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
AU2016335287A1 (en) 2015-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical formulations for the oral delivery of peptide drugs
JP2019505535A (ja) * 2016-02-05 2019-02-28 エントレガ，インコーポレイテッド 活性剤の送達のための乾燥剤を含む経口製剤
WO2017143294A1 (en) 2016-02-18 2017-08-24 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
DK3570821T3 (da) 2017-01-23 2021-10-11 Afyx Therapeutics As Fremgangsmåde til fremstilling af et tolagsprodukt på basis af elektrospundne fibre
US20180235899A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
DK3624887T3 (da) 2017-05-17 2025-05-19 Massachusetts Inst Technology Vævforankringsartikler
US11291629B2 (en) 2017-06-27 2022-04-05 Bioserentach Co., Ltd. Mucoadhesive oral preparation
JP7442823B2 (ja) 2018-04-06 2024-03-05 シプルメット・ゲーエムベーハー 治療用ペプチド及び治療用タンパク質の経粘膜送達のための薬学的組成物
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
US11771829B2 (en) 2019-02-01 2023-10-03 Massachusetts Institute Of Technology Systems and methods for liquid injection
MX2022001865A (es) * 2019-08-12 2022-03-11 Massachusetts Inst Technology Articulos y metodos para la administracion de agentes terapeuticos.
US11793980B2 (en) 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
CN116419750A (zh) 2020-09-07 2023-07-11 西普鲁梅有限公司 改进的glp-1受体激动剂的药物制剂
JP2024514047A (ja) 2021-03-15 2024-03-28 エピトミー メディカル リミテッド 組織に活性剤を送達するための拡張可能なデバイス
JP2025508982A (ja) 2022-03-03 2025-04-10 サイプルメド ゲーエムベーハー 治療用ペプチドおよびタンパク質の改善された経口医薬製剤
CA3268033A1 (en) 2022-09-21 2024-03-28 Epitomee Medical Ltd. Ingestable, self-expanding devices that can disintegrate in a controllable manner

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
US20030017195A1 (en) * 2001-07-20 2003-01-23 Samir Mitragotri Method for oral drug delivery
WO2003066572A1 (en) * 2002-02-07 2003-08-14 Wisconsin Alumni Research Foundation Polyamine compounds and compositions for use in conjunction with cancer therapy
JP5165240B2 (ja) * 2003-07-23 2013-03-21 ピーアール ファーマシューティカルズ， インコーポレイテッド 徐放組成物
WO2007070632A2 (en) * 2005-12-13 2007-06-21 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US20090110717A1 (en) * 2006-05-02 2009-04-30 Amarjit Singh Transmucosal composition
JP5005422B2 (ja) * 2007-05-09 2012-08-22 株式会社エンプラス 射出成形ギヤ
AU2011329066B2 (en) * 2010-11-15 2017-03-09 The Ohio State University Research Foundation Controlled release mucoadhesive systems
ES2546780T3 (es) * 2011-04-04 2015-09-28 Coloplast A/S Parche adhesivo

Similar Documents

Publication Publication Date Title
JP2015519403A5 (enExample)
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
PH12015501756A1 (en) Tamper resistant pharmaceutical formulations
MX2014011626A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo.
WO2011107855A3 (en) Sustained release oral liquid suspension dosage form
AR073704A1 (es) Sistema de administracion transdermal de droga para principios activos liquidos que tiene una capa de matriz adhesiva que incluye un ingrediente farmaceutico activo que es seleccionado entre selegilina y rivastigmina
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2014528431A5 (enExample)
PE20190105A1 (es) Formas de dosificacion de liberacion modificada disuasivas de abuso
PE20142035A1 (es) Formulacion compuesta que comprende un comprimido esferoidal de multiples unidades (must) encapsulada en una capsula dura y metodo para preparar la misma
WO2006023286A3 (en) Controlled release nanoparticle active agent formulation dosage forms and methods
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos
JP2013047264A5 (enExample)
CR20150077A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
JP2014526519A5 (enExample)
WO2014130553A3 (en) Tablet dosage form comprising ritonavir and lopinavir
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
JP2014514104A5 (enExample)
JP2015508411A5 (enExample)
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
JP2008510713A5 (enExample)
WO2017123315A3 (en) Nanocrystals formed in a microenvironment
ES2606399T3 (es) Formulación sólida de liberación controlada para administración oral en un sobre de dosis única y método de preparación de la misma
NZ712265A (en) Phenylephrine resinate particles and use thereof in pharmaceutical formulations